Edgewise Therapeutics, Inc. (EWTX) earnings
Quarterly results of Edgewise Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Edgewise Therapeutics, Inc. is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Edgewise Therapeutics, Inc. reported revenue of - and net income of $1.2B.
Diluted earnings per share were $9.65.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | $1.2B | $9.65 |
| Q2 FY2026 | - | - | -$57.3M | -$0.53 |
| Q1 FY2026 | - | - | -$49M | -$0.46 |
| Q4 FY2025 | - | - | -$50.2M | - |
| Q3 FY2025 | - | - | -$40.7M | -$0.39 |
| Q2 FY2025 | - | - | -$36.1M | -$0.34 |
| Q1 FY2025 | - | - | -$40.8M | -$0.43 |
| Q4 FY2024 | - | - | -$39.7M | - |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Quarterly report 10-Q
When is Edgewise Therapeutics, Inc.'s next earnings date?
Edgewise Therapeutics, Inc. is expected to report around February 25, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when EWTX reports
Follow EWTX and we email you its next results the day they are filed, with the numbers explained.